Jump to Content Jump to Main Navigation

Volume 10 (2012): Issue 5 (May 2012)

in Journal of the National Comprehensive Cancer Network

Online ISSN:: 1540-1413

Print ISSN:: 1540-1405

Cover Journal of the National Comprehensive Cancer Network

NCCN News

Pages: xv–xxi
Oncology Research Program

Pages: xxxiii–xxxiv
Continuing the Conversation: Questions on Cancer Care from the NCCN Annual Conference

By: Staff

Pages: 567
Ten Years of Progress in Colon Cancer Therapy

By: Paul F. Engstrom

Pages: 574–576
A Case of Diffuse Large B-Cell Lymphoma in Association With Paraesophageal Leiomyoma: Highlighting False-Positivity of PET Scan and Importance of Tissue Diagnosis

By: Rajinder S. Grover, Kemp Kernstine and Amrita Krishnan

Pages: 577–581
Where is the EHR in Oncology?

By: Jeremy Warner and Ephraim Hochberg

Pages: 584–588
Hodgkin Lymphoma, Version 2.2012 Featured Updates to the NCCN Guidelines

By: Richard T. Hoppe, Ranjana H. Advani, Weiyun Z. Ai, Richard F. Ambinder, Patricia Aoun, Celeste M. Bello, Philip J. Bierman, Kristie A. Blum, Robert Chen, Bouthaina Dabaja, Ysabel Duron, Andres Forero, Leo I. Gordon, Francisco J. Hernandez-Ilizaliturri, Ephraim P. Hochberg, David G. Maloney, David Mansur, Peter M. Mauch, Monika Metzger, Joseph O. Moore, David Morgan, Craig H. Moskowitz, Matthew Poppe, Barbara Pro, Jane N. Winter, Joachim Yahalom and Hema Sundar

Pages: 589–597
The Management of Patients With Stage IIIA Non–Small Cell Lung Cancer With N2 Mediastinal Node Involvement

By: Renato G. Martins, Thomas A. D’Amico, Billy W. Loo Jr, Mary Pinder-Schenck, Hossein Borghaei, Jamie E. Chaft, Apar Kishor P. Ganti, Feng-Ming (Spring) Kong, Mark G. Kris, Inga T. Lennes and Douglas E. Wood

Pages: 599–613
Oral Chemotherapy Program Improves Adherence and Reduces Medication Wastage and Hospital Admissions

By: Nikhil Khandelwal, Ian Duncan, Tamim Ahmed, Elan Rubinstein and Cheryl Pegus

Pages: 618–625
Cancer- and Chemotherapy-Induced Anemia

By: George M. Rodgers III, Pamela Sue Becker, Morey Blinder, David Cella, Asher Chanan-Khan, Charles Cleeland, Peter F. Coccia, Benjamin Djulbegovic, Jeffrey A. Gilreath, Eric H. Kraut, Ursula A. Matulonis, Michael M. Millenson, Denise Reinke, Joseph Rosenthal, Rowena N. Schwartz, Gerald Soff, Richard S. Stein, Gordana Vlahovic and Alva B. Weir III

Pages: 628–653
Update on Safety of ESAs in Cancer-Induced Anemia

By: John Glaspy

Pages: 659–666
Total Dose Iron Dextran Infusion in Cancer Patients: Is it SaFe²⁺?

By: Jeffrey A. Gilreath, David D. Stenehjem and George M. Rodgers

Pages: 669–676
Measuring the Evidence That Informs Clinical Treatment Recommendations

By: Jonathan L. Vandergrift

Pages: 678–680